Search results
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 4 days agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
Merck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Simply Wall St. via Yahoo Finance· 1 day agoMerck & Co., Inc. (NYSE:MRK) just released its quarterly report and things are looking bullish. The...
Merck KGaA (ETR:MRK) Is Due To Pay A Dividend Of €2.20
Simply Wall St. via Yahoo Finance· 16 hours agoThe board of Merck KGaA (ETR:MRK) has announced that it will pay a dividend of €2.20 per share on...
Dow Jones Darling Merck Pops As Cancer 'Star' Drives Quarterly Beat
Investor's Business Daily· 3 days agoMerck's bread-and-butter cancer drug grew by double digits again in the first quarter.
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 6 days agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...
Merck stock gains on Q1 2024 beat (NYSE:MRK)
Seeking Alpha· 3 days agoMerck (MRK) stock gains as the company posts better than expected Q1 2024 financials with strong sales growth from its cancer medicine Keytruda. Read...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
Reuters· 4 days agoThe New Jersey-based drugmaker said it expected earnings of $8.53 and $8.65 per share, up from its...
Merck stock target raised on strong Q1 results By Investing.com
Investing.com· 2 days agoOn Friday, Wells Fargo adjusted its outlook on shares of pharmaceutical giant Merck & Co., Inc....
Merck&Co earnings beat by $0.14, revenue topped estimates
Investing.com· 4 days agoMerck&Co earnings beat by $0.14, revenue topped estimates
Will Higher Keytruda Sales Drive Merck's Q1
Forbes· 5 days agoMerck (NYSE: MRK) will report its Q1 2024 results on Thursday, April 25. As usual, Keytruda will be the driving growth for Merck with quarterly sales...
